Current status of theranostics in prostate cancer.

about

Oxygen Sensing, Hypoxia Tracing and in Vivo Imaging with Functional Metalloprobes for the Early Detection of Non-communicable Diseases.

P2860

Q52661554-D54272FD-5AE0-4369-926E-4F473BBE19E9

P2860

Current status of theranostics in prostate cancer.

Item

http://www.wikidata.org/entity/Q47241139

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Current status of theranostics in prostate cancer.

@en

Current status of theranostics in prostate cancer.

@nl

type

Item

label

Current status of theranostics in prostate cancer.

@en

Current status of theranostics in prostate cancer.

@nl

prefLabel

Current status of theranostics in prostate cancer.

@en

Current status of theranostics in prostate cancer.

@nl

P1476

Current status of theranostics in prostate cancer

@en

P2093

Christian Uprimny

http://www.w3.org/2001/XMLSchema#string

Irene Virgolini

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen

Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)

Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer

Indium-111 capromab pendetide in the management of recurrent prostate cancer

Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

Alpha emitter radium-223 and survival in metastatic prostate cancer

Radium-223 dichloride in clinical practice: a review.

PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.

P2888

s00259-017-3882-2

P304

471-495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00259-017-3882-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Clemens Decristoforo

Alexander R Haug

Stefano Fanti

P5008

ScienceSource

P577

2017-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29282518

http://www.w3.org/2001/XMLSchema#string

P921

prostate cancer

P932

5787224

http://www.w3.org/2001/XMLSchema#string

Current status of theranostics in prostate cancer.

about

P2860

P2860

Current status of theranostics in prostate cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P698

P921

P932